COVID-19 Vaccine
AGC Biologics Supports Omicron-Based Vaccine Candidate Manufacturing with Starting Material
AGC Biologics
PR-M02-22-07Feb 09, 2022
COVID-19 Research
MU Study Identifies Mutations Specific to Omicron Variant
University of Missouri
PR-M01-22-17Jan 25, 2022